Literature DB >> 26772195

Parathyroidectomy or Calcimimetic to Treat Hypercalcemia after Kidney Transplantation?

Masafumi Fukagawa1, Tilman B Drüeke2.   

Abstract

Entities:  

Keywords:  calcium; calcium receptor; hyperparathyroidism; kidney transplantation; parathyroid hormone

Mesh：

Substances：

Year:  2016        PMID： 26772195      PMCID： PMC4978062          DOI： 10.1681/ASN.2015121349

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  14 in total

Review 1.  Mineral and bone disorders in kidney transplant recipients: reversible, irreversible, and de novo abnormalities.

Authors:  Takashi Hirukawa; Takatoshi Kakuta; Michio Nakamura; Masafumi Fukagawa
Journal:  Clin Exp Nephrol       Date:  2015-05-02       Impact factor: 2.801

2.  Persistent hyperparathyroidism in renal allograft recipients: vitamin D receptor, calcium-sensing receptor, and apoptosis.

Authors:  M Taniguchi; M Tokumoto; D Matsuo; K Motoyama; A Sugitani; S Kuroki; H Yotsueda; K Tsuruya; H Hirakata; M Iida
Journal:  Kidney Int       Date:  2006-05-31       Impact factor: 10.612

3.  A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism.

Authors:  P Evenepoel; K Cooper; H Holdaas; P Messa; G Mourad; K Olgaard; B Rutkowski; H Schaefer; H Deng; J V Torregrosa; R P Wuthrich; S Yue
Journal:  Am J Transplant       Date:  2014-09-15       Impact factor: 8.086

Review 4.  Parathyroidectomy after successful kidney transplantation: a single centre study.

Authors:  Pieter Evenepoel; Kathleen Claes; Dirk R Kuypers; Frans Debruyne; Yves Vanrenterghem
Journal:  Nephrol Dial Transplant       Date:  2007-03-19       Impact factor: 5.992

5.  Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Authors:  Sharon M Moe; Glenn M Chertow; Patrick S Parfrey; Yumi Kubo; Geoffrey A Block; Ricardo Correa-Rotter; Tilman B Drüeke; Charles A Herzog; Gerard M London; Kenneth W Mahaffey; David C Wheeler; Maria Stolina; Bastian Dehmel; William G Goodman; Jürgen Floege
Journal:  Circulation       Date:  2015-06-09       Impact factor: 29.690

Review 6.  Current indications to parathyroidectomy in CKD patients before and after renal transplantation.

Authors:  Piergiorgio Messa; Anna Regalia; Carlo Maria Alfieri; Donata Cresseri; Laura Forzenigo; Maria Teresa Gandolfo; Maria Pia Rastaldi
Journal:  J Nephrol       Date:  2013-11-19       Impact factor: 3.902

Review 7.  Cinacalcet for the treatment of hyperparathyroidism in kidney transplant recipients: a systematic review and meta-analysis.

Authors:  Jordana B Cohen; Craig E Gordon; Ethan M Balk; Jean M Francis
Journal:  Transplantation       Date:  2012-11-27       Impact factor: 4.939

8.  KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Authors: 
Journal:  Kidney Int Suppl       Date:  2009-08       Impact factor: 10.545

9.  A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism.

Authors:  Josep M Cruzado; Pablo Moreno; José V Torregrosa; Omar Taco; Richard Mast; Carmen Gómez-Vaquero; Carolina Polo; Ignacio Revuelta; José Francos; Joan Torras; Arantxa García-Barrasa; Oriol Bestard; Josep M Grinyó
Journal:  J Am Soc Nephrol       Date:  2015-12-08       Impact factor: 10.121

10.  Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia.

Authors:  A Arnold; M F Brown; P Ureña; R D Gaz; E Sarfati; T B Drüeke
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808
View more
  1 in total

Review 1.  Mineral and Bone Disorders After Kidney Transplantation.

Authors:  Chandan Vangala; Jenny Pan; Ronald T Cotton; Venkat Ramanathan
Journal:  Front Med (Lausanne)       Date:  2018-07-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.